calendar
7,244 catalysts · 4,301 phase readout · 2,247 8k filing · 282 earnings · 172 phase 2 completion · 93 drug shortage · 73 phase 1 completion
7,244 catalysts · 4,301 phase readout · 2,247 8k filing · 282 earnings · 172 phase 2 completion · 93 drug shortage · 73 phase 1 completion
Therapy area: Dermatology. Indication: Vitiligo
Therapy area: Women's Health. Indication: Menorrhagia
Therapy area: Immunology. Indication: Kidney Transplant Rejection
Therapy area: Cardiovascular. Indication: Hypotension
Therapy area: Immunology. Indication: Cutaneous Lupus Erythematosus, Systemic Lupus Erythematosus
Therapy area: Gastrointestinal, Genito Urinary System, Infectious Disease. Indication: Gonorrhea, Intestinal Infection, Salmonella Infections, Typhoid Fever, Urinary Tract Infections
Therapy area: Central Nervous System. Indication: Post-Operative Pain
Therapy area: Oncology. Indication: Multiple Myeloma (Kahler Disease), Refractory Multiple Myeloma
Therapy area: Oncology, Toxicology. Indication: Chemotherapy Induced Acral Erythema (Hand-Foot Syndrome), Colon Tumor
Therapy area: Respiratory. Indication: Idiopathic Pulmonary Fibrosis, Interstitial Lung Fibrosis
Therapy area: Infectious Disease. Indication: Hepatitis B
Therapy area: Oncology. Indication: Hormone-Sensitive Prostate Cancer, Metastatic Castration-Resistant Prostate Cancer (mCRPC), Metastatic Prostate Cancer, Prostate Cancer
Therapy area: Gastrointestinal. Indication: Irritable Bowel Syndrome
Therapy area: Central Nervous System. Indication: Addictive Disorders, Smoking Cessation
Therapy area: Central Nervous System, Musculoskeletal Disorders. Indication: Osteoarthritis, Post-Operative Pain
Therapy area: Genito Urinary System, Oncology. Indication: Bladder Cancer, Bladder Carcinoma, Kidney Cancer (Renal Cell Cancer), Metastatic Transitional (Urothelial) Tract Cancer, Renal Stones/Calculi, Transitional Cell Cancer (Urothelial Cell Cancer), Transitional Cell Carcinoma (Urothelial Cell Carcinoma), Ureter Cancer, Urethral Cancer
Therapy area: Oncology. Indication: Head And Neck Cancer, Head And Neck Squamous Cell Carcinoma (HNSC), Hypopharyngeal Cancer, Laryngeal Cancer, Oral Cavity (Mouth) Cancer, Oropharyngeal Cancer, Recurrent Head And Neck Squamous Cell Carcinoma
Therapy area: Oncology. Indication: Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)
Therapy area: Respiratory. Indication: Seasonal Allergic Rhinitis
Therapy area: Ophthalmology. Indication: Open-Angle Glaucoma
Therapy area: Metabolic Disorders. Indication: Fabry Disease
Therapy area: Metabolic Disorders. Indication: Type 2 Diabetes
Therapy area: Central Nervous System. Indication: Pain
Therapy area: Oncology. Indication: Small-Cell Lung Cancer
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 2.02, 7.01, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 7.01, 8.01, 9.01
Items: 2.02, 9.01
Items: 2.02, 5.02, 9.01
Items: 2.02, 7.01, 8.01, 9.01
Items: 3.01
Items: 1.01, 7.01, 9.01
Items: 2.02, 7.01, 9.01
Items: 5.07
Items: 7.01, 9.01
Items: 5.02
Items: 2.02, 7.01, 9.01
Items: 5.02
Items: 2.02
Items: 2.02, 9.01
Items: 5.03, 9.01
Items: 3.01, 7.01, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 5.03, 5.07, 9.01
Items: 2.02, 9.01